mifepristone has been researched along with Leiomyomatosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, R; Carbonell Esteve, JL; Castañeda, MC; Heredia, B; Hernández, AV; Pérez, Y | 1 |
| Bagaria, M; Guleria, K; Mishra, K; Suneja, A; Vaid, NB | 1 |
| Eisinger, SH; Feng, C; Fiscella, K; Fisher, SG; Guzick, DS; Meldrum, S | 1 |
| Kettel, LM; Morales, AJ; Murphy, AA; Yen, SS | 1 |
4 trial(s) available for mifepristone and Leiomyomatosis
| Article | Year |
|---|---|
Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Leiomyomatosis; Middle Aged; Mifepristone; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus | 2008 |
Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial.
Topics: Adult; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Female; Follicular Phase; Hormone Antagonists; Humans; Leiomyomatosis; Menorrhagia; Middle Aged; Mifepristone; Placebos; Uterine Neoplasms | 2009 |
Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
Topics: Adult; Female; Hormone Antagonists; Humans; Leiomyomatosis; Middle Aged; Mifepristone; Organ Size; Pain; Quality of Life; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus | 2006 |
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Humans; Leiomyomatosis; Middle Aged; Mifepristone; Prospective Studies; Ultrasonography; Uterine Neoplasms | 1995 |